Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A survey led by Nuffield Department of Population Health's Health Economics Research Centre has found that most people in high-income countries support donating some of their country’s COVID-19 vaccine supplies to low-income nations who would otherwise struggle to gain access.

Syringe and vaccine vial

Researchers conducted an anonymous online survey which had over 8,000 respondents across seven high-income countries (Australia, Canada, France, Italy, Spain, UK and the USA). The survey was carried out between 24 November and 28 December 2020, when an effective vaccine was expected to soon be available. The findings are published today in Nature Medicine.

The study’s main findings were:

  • For each country assessed, the number of people who supported donating vaccines was at least double those who did not. Support for donating vaccines ranged from 48–56%, whilst 15–26% did not support donating vaccines and 22–28% were undecided.
  • Of those who supported vaccine donations, most (73–81%) favoured an amount greater than or equal to 10% of their country’s doses.
  • When asked how much they agreed with three prioritisation principles for global vaccine distribution, the highest-ranking principle for each country was need, with average agreement ranging from 70–80 (where 0 means very much disagree and 100 means very much agree). This was followed by prioritising countries which could not afford to buy vaccines otherwise (62–70 average agreement), and finally whether the country itself had developed the vaccine (28–58 average agreement).

Read the full story on theNuffield Department of Population Health website

The story is also featured on the University of Oxford website.

Similar stories

Labelling proteins through the diet gives new insights into how collagen-rich tissues change as we age

A new study, published in eLife, uses advanced tissue analysis technology to show how the incorporation of new proteins changes in bone and cartilage with age.

Drug could help diabetic hearts recover after heart attack - Oxford research

Researchers at the University of Oxford have identified a drug that could ultimately help improve heart function in people with diabetes who have heart attacks.

Largest ever global study of tuberculosis identifies genetic causes of drug resistance

Using cutting-edge genomic sequencing techniques, researchers at the University of Oxford have identified almost all the genomic variation that gives people resistance to 13 of the most common tuberculosis (TB) drug treatments.

Peter Horby receives prestigious award for outstanding service to public health

The Faculty of Public Health (FPH) has awarded its prestigious Alwyn Smith Prize to Professor Sir Peter Horby (Nuffield Department of Medicine) for 2020/2021 in recognition of his outstanding service to public health as a global leader in epidemic science.

Six new Fellowships announced as part of Oxford-Bristol Myers Squibb Fellowships Programme

The Oxford - Bristol Myers Squibb (BMS) Fellowships Programme continued to demonstrate significant progress over the last year, despite the challenges associated with the global pandemic, including restricted lab access and work from home guidance. Today, we are pleased to announce six new Oxford-BMS Fellowships for 2021.

Researchers set out steps to address mental health effects of the pandemic on young people

Researchers have outlined 14 steps that schools, mental health services and policymakers can take to help children and young people whose mental health has been affected by the COVID-19 pandemic.